First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases

被引：0
|
作者：
Weili Sun
Huaying Liu
Young Kim
Nicole Karras
Anna Pawlowska
Debbie Toomey
Wade Kyono
Paul Gaynon
Joseph Rosenthal
Anthony Stein
机构：
[1] City of Hope National Medical Center,Department of Pediatrics
[2] Southern Medical University,Department of Pediatrics, Nanfang Hospital
[3] City of Hope National Medical Center,Department of Pathology
[4] University of Hawaii,Department of Pediatrics, Kapiolani Medical Center for Women and Children
[5] University of Southern California,Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles
[6] City of Hope National Medical Center,Department of Hematology and Hematopoietic Cell Transplantation
来源：
Journal of Hematology & Oncology | / 11卷
关键词：
Pediatric; BPDCN; SL-401; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Tagraxofusp, an Anti-CD123 Therapy, in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm and Prior or Concomitant Hematologic Malignancies: Subgroup Analysis of a Pivotal Trial
    Pemmaraju, Naveen
    Konopleva, Marina
    Sweet, Kendra
    Stein, Anthony
    Vasu, Sumithira
    Rizzieri, David
    Wang, Eunice S.
    Kantarjian, Hagop
    Brooks, Christopher
    Mughal, Tariq
    Lane, Andrew A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S288 - S288
  • [42] Preclinical efficacy of allogeneic anti-CD123 CAR T-cells for the therapy of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
    Cai, Tianyu
    Black, Kathryn L.
    Naqvi, Ammar
    Galetto, Roman
    Gouble, Agnes
    Smith, Julianne
    Cavazos, Antonio
    Han, Lina
    Zhang, Qi
    Kuruvilla, Vinitha
    Konoplev, Sergej Naumovich Sergej
    Neelapu, Sattva S.
    Lane, Andrew A.
    Guzman, Monica L.
    Kantarjian, Hagop
    Thomas-Tikhonenko, Andrei
    Pemmaraju, Naveen
    Konopleva, Marina
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Tagraxofusp, an Anti-CD123 Therapy, in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm: Sub-Analysis of a Pivotal Trial by Age and Baseline Disease Involvement
    Pemmaraju, Naveen
    Konopleva, Marina
    Sweet, Kendra
    Stein, Anthony
    Vasu, Sumithira
    Rizzieri, David
    Wang, Eunice S.
    Kantarjian, Hagop
    Brooks, Chris
    Mughal, Tariq
    Lane, Andrew
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S254 - S254
  • [44] Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patient-Derived Xenografts Are Faithful Genomic and Phenotypic Models of Primary Leukemia and Respond to the IL3 Receptor Targeting Agent SL-401 In Vivo
    Christie, Amanda L.
    Li, Yvonne
    Togami, Katsuhiro
    Ghandi, Mahmoud
    Christodoulou, Alexandra N.
    Buczkowski, Kevin
    Angelot-Delettre, Fanny
    Biichle, Sabeha
    Chen, Janice
    Brooks, Christopher L.
    Weinstock, David M.
    Garnache-Ottou, Francine
    Hammerman, Peter S.
    Lane, Andrew A.
    BLOOD, 2015, 126 (23)
  • [45] Experience with IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Frontline Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Pemmaraju, Naveen
    Martinelli, Giovanni
    Todisco, Elisabetta
    Lane, Andrew A.
    Acuna-Cruz, Evelyn
    Deconinck, Eric
    Wang, Eunice S.
    Sweet, Kendra
    Rizzieri, David A.
    Marconi, Giovanni
    Mazzarella, Luca
    DeAngelo, Daniel J.
    Montesinos, Pau
    Gigli, Federica
    Erba, Harry P.
    Konopleva, Marina
    Kantarjian, Hagop
    Walter, Roland B.
    Aribi, Ahmed
    Lebon, Delphine
    Levy, Moshe Y.
    Sloss, Callum M.
    Malcolm, Kara E.
    Zweidler-McKay, Patrick A.
    Daver, Naval
    BLOOD, 2021, 138
  • [46] Lead-in Stage Results of a Pivotal Trial of SL-401, an Interleukin-3 Receptor (IL-3R) Targeting Biologic, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) or Acute Myeloid Leukemia (AML)
    Sweet, Kendra L.
    Pemmaraju, Naveen
    Lane, Andrew A.
    Stein, Anthony S.
    Vasu, Sumithira
    Blum, William
    Rizzieri, David A.
    Wang, Eunice S.
    Rowinsky, Eric K.
    Szarek, Michael
    Brooks, Christopher L.
    Disalvatore, Sarah
    Liu, David
    Duvic, Madeleine
    Schwartz, Jonathan D.
    Konopleva, Marina
    BLOOD, 2015, 126 (23)
  • [47] Pre-Clinical Studies of Allogeneic Anti-CD123 CAR T-Cells for the Therapy of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Cai, Tianyu
    Galetto, Roman
    Gouble, Agnes
    Smith, Julianne
    Cavazos, Antonio
    Han, Lina
    Zhang, Qi
    Kuruvilla, Vinitha Mary
    Konoplev, Sergej Naumovich
    Neelapu, Sattva S.
    Lane, Andrew A.
    Guzman, Monica L.
    Kantarjian, Hagop M.
    Pemmaraju, Naveen
    Konopleva, Marina
    BLOOD, 2017, 130
  • [48] SL-401, a Novel Targeted Therapy Directed to the Interleukin-3 Receptor (IL-3R), Blocks Plasmacytoid Dendritic Cell (pDC)-Triggered Myeloma Cell Growth and Prevents Osteoclastogenesis
    Ray, Arghya
    Das, Deepika Sharma
    Ravillah, Durgadevi
    Song, Yan
    Macri, Vincent
    Brooks, Christopher
    Rowinsky, Eric
    Richardson, Paul G.
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BLOOD, 2014, 124 (21)
  • [49] Usefulness of Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm With Skin Involvement: A Case Report and Review of Literature
    Sakashita, Kazuo
    Saito, Shoji
    Yanagisawa, Ryu
    Tanaka, Miyuki
    Yoshikawa, Kentaro
    Hirabayashi, Koichi
    Tsukahara, Keiko
    Motobayashi, Mitsuo
    Nakazawa, Yozo
    Koike, Kenichi
    PEDIATRIC BLOOD & CANCER, 2013, 60 (11) : E140 - E142
  • [50] Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation
    Jiang, Yi-li
    Li, Qing
    Yuan, Ting
    Jiang, Yan-yu
    Deng, Qi
    ONCOTARGETS AND THERAPY, 2020, 13 : 3425 - 3430
12345